Sp736
THE ROLE OF FIBROBLASTS IN FIBROSTENOSING CROHN'S DISEASE
Date
May 20, 2024
Explore related products in the following collection:
Presenter
Cleveland Clinic Foundation
Tracks
Related Products
TRANSGLUTAMINASE 2 IS ELEVATED IN CROHN’S DISEASE ASSOCIATED STRICTURES AND EXERTS PROFIBROTIC ACTIVITIES IN MYOFIBROBLASTS AND EXPERIMENTAL INTESTINAL FIBROSIS
BACKGROUND: Inflammatory bowel disease (IBD)-associated intestinal fibrosis is a significant clinical problem. Excessive accumulation of extracellular matrix (ECM) derived from intestinal myofibroblasts (HIMF) is a hallmark of intestinal strictures…
INTEGRIN INHIBITION REDUCES PROFIBROTIC RESPONSES IN CROHN’S DISEASE (CD) HUMAN INTESTINAL MYOFIBROBLASTS IN VITRO AND AMELIORATES EXPERIMENTAL INTESTINAL FIBROSIS IN VIVO - A POTENTIAL NOVEL APPROACH TO CD STRICTURE THERAPY
_INTRODUCTION:_ Despite effective anti-inflammatory therapies, ~70% of CD patients require surgery in their lifetime, due to fibrostenotic strictures linked to excess extracellular matrix (ECM) deposition…
